Vitiligo-like depigmentation in patients receiving programmed cell death-1 inhibitor reflects active vitiligo

J Am Acad Dermatol. 2018 Jan;78(1):e15-e16. doi: 10.1016/j.jaad.2017.07.058.

Authors

Keitaro Fukuda¹, John E Harris²

Affiliations

¹ Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.
² Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts. Electronic address: john.harris@umassmed.edu.

PMID: 29241799
DOI: 10.1016/j.jaad.2017.07.058

No abstract available

Publication types

Letter
Comment

MeSH terms

Cell Death
Humans
Hypopigmentation*
Pigmentation Disorders
Vitiligo*